Spyre Therapeutics
SYRE
#3600
Rank
NZ$6.56 B
Marketcap
NZ$83.56
Share price
-2.70%
Change (1 day)
230.98%
Change (1 year)

Revenue for Spyre Therapeutics (SYRE)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spyre Therapeutics from 2014 to 2025

Annual revenue

Year Revenue Change
2025 N/A
2024 N/A-100%
2023 NZ$1.4 M-61.81%
2022 NZ$3.66 M-86.63%
2021 NZ$27.43 M
2020 N/A
2019 N/A-100%
2018 NZ$5.79 M-20.9%
2017 NZ$7.32 M9.67%
2016 NZ$6.68 M-24.85%
2015 NZ$8.89 M
2014 N/A